If you are on the hunt for a low-priced marijuana stock with big upside potential, then OrganiGram Holdings Inc(OTCMKTS:OGRMF, CVE:OGI) deserves your attention.

Compared to the big-name pot stocks, OrganiGram seems like a relatively small player in the business, with a market capitalization of just under CA$1.3 billion.

And like many smaller pot stocks, the company is listed on the TSX Ventures Exchange in Canada. Still, it’s possible for American investors to get a piece of the action. That’s because the company’s shares can be bought in the U.S. over the counter.

Unique Market Opportunity

The big question now, of course, is why investors should consider OrganiGram stock over the more popular tickers in the cannabis industry.

Cannabis stocks have enjoyed a nice recovery in the first quarter of 2019 and investors are wondering which marijuana stocks might be attractive buys today as the industry continues to evolve.

Let’s take a look at HEXO (TSX:HEXO) to see if it deserves to be in your portfolio today.

HEXO

HEXO just reported fiscal Q2 2019 results that show the company is steadily growing. Gross revenue jumped 144% compared to the previous quarter, supported by recreational marijuana sales in Canada and a 39% increase in dried cannabis production.

The marijuana industry is on fire, and it's not hard to understand why.

According to a handful of Wall Street investment banks, the legal weed industry is on track for as much as $50 billion to $75 billion in global annual sales by the end of the next decade.

That'd place the cannabis industry more or less on par with the global soda industry, and it would mean a lot of dollars flowing into the eventual winners in the pot space.

The big question is, which marijuana stocks to buy?

The marijuana stock market of the past year or two has changed vastly from where it was in its early days. Of course, this is characteristic of any industry, but it seems as though marijuana is shifting quicker than ever before.

Many stocks have been able to come into the forefront of the industry amidst the new state of the industry, but the ones that are seeing the most bullish sentiment are the ones putting forth the most innovation for the future of the market. These companies are few and far between, but it seems as though if one does there research, it may not be as hard to find after all.

Investorideas.com, a leading investor news resource covering tech and cannabis stocks, releases a snapshot looking at how payment technology and data solutions have evolved due to the regulatory hurdles facing the cannabis industry.

PaymentsJournal discussed the “cannabis payments conundrum” and how as the cannabis industry matures we are beginning to see an evolution in payment and data tech companies.

Cannabis stocks sank like a stone on Wednesday, with broad losses across North American markets. 

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, dropped 2.5% to 297.45 by Wednesday's close. The Horizons Marijuana Life Sciences Index ETF was down 3.8% at C$21.93. 

Duds

Leading the pack and hot on the heels of a downgrade was Cronos Group Inc (NASDAQ:CRON) (TSE:CRON) after Cannaccord analysts downgraded the stock from Hold to Sell, with a price target of C$6.50. 

Canada has been leading the charge for the world of legal cannabis for quite some time now. In the past few years, the market on Canadian weed has drastically shifted allowing for the entrance of many companies that never before would’ve entered the industry. While so many other nations including various states in the U.S., are attempting to work on having their own large legal cannabis markets, it seems as though Canada is still coming out on top.

This is partly due to the length that their legal industry has been around, but partly due to the friendliness of entering the market from the northern nation. All in all, Canada seems to have many companies to keep a close eye on for investors in the marijuana market.

 Although often overshadowed by the importance of marijuana retail and branding, cannabis extraction is a vital component of any vertically integrated cannabis company. Not only do in-house extraction operations allow cannabis companies to avoid outsourcing costs, but it also enables the potential for additional revenue streams and more rapid product ideation. With cannabis edibles, extracts, and topicals expected to be legal in the Canadian market later this year, we examine some of the marijuana industry’s largest cannabis extractors.

Beloved Vancouverite Seth Rogen launched a new brand of Canadian recreational cannabis called Houseplant on Wednesday, March 27.

The Pineapple Express star founded the Toronto-based brand with screenwriter Evan Goldberg in collaboration with Canopy Growth, a global cannabis and hemp company. The company launches after years of work designing a product that will, “make it easier for people to learn to love cannabis as much as Houseplant does.”

“Houseplant is a passion we’ve brought to life through drive and dedication,” said Seth Rogen, Co-Founder of Houseplant.  “Every decision we’ve made for the business reflects the years of education, first-hand experience and respect we have for cannabis.”

When it comes to growth, no industry is expected to pile on the green, at least from a revenue perspective, more than legal cannabis. This year alone, global weed sales are expected to grow from an estimated $12.2 billion to $16.9 billion (that's 38% for those of you keeping score at home), according to Arcview Market Research and BDS Analytics. Most of this growth will come from Canada's steady ramp-up of recreational pot sales, as well as California working out some early kinks in its adult-use market and supply chain.